MedTrace Logo

Single and Multiple Ascending Dose Study for NKTR-118 and Cross-over Study to Investigate the Effect of Food for NKTR-118 in Japanese Healthy Subjects

NCT01318655 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-08-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and tolerability of NKTR-118 with healthy subjects.

Conditions

  • Healthy

Interventions

DRUG

NKTR-118

Tablet, Oral, Once daily

DRUG

Placebo

Tablet, Oral, Once daily

Sponsors & Collaborators

Principal Investigators

  • Mark Sostek, MD · AstraZeneca

  • Shunji Matsuki, MD · Kyusyu Clinical Phramacology Research Clinic

  • Yukiya Sasaki, MD · AstraZeneca

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01318655 on ClinicalTrials.gov